Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,082 | -30,008 | -27,299 | -30,340 | -12,099 |
| Depreciation Amortization | 79 | 224 | 239 | 126 | N/A |
| Other Working Capital | 1,037 | 10,436 | -2,864 | -3,086 | 44 |
| Other Operating Activity | 7,605 | 7,368 | 7,238 | 4,796 | 3,112 |
| Operating Cash Flow | $-33,361 | $-11,980 | $-22,686 | $-28,504 | $-8,943 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | -15,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -15,000 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-15,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 14,951 | N/A |
| Debt Repayment | -10,000 | -5,000 | N/A | N/A | N/A |
| Common Stock Issued | 28,211 | 775 | 729 | 81,406 | 24,907 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1,012 |
| Financing Cash Flow | $18,211 | $-4,225 | $729 | $96,357 | $23,895 |
| Exchange Rate Effect | 224 | -100 | -700 | -10 | 19 |
| Beginning Cash Position | 35,848 | 52,153 | 74,810 | 21,967 | 6,996 |
| End Cash Position | 20,922 | 35,848 | 52,153 | 74,810 | 21,967 |
| Net Cash Flow | $-14,926 | $-16,305 | $-22,657 | $52,843 | $14,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,361 | -11,980 | -22,686 | -28,504 | -8,943 |
| Free Cash Flow | -33,361 | -11,980 | -22,686 | -28,504 | -8,943 |